These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16758722

  • 1. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K, Yamagishi T, Suzuki K, Kondo K, Kishida T, Saito K, Sekiguchi Y, Nakaigawa N, Ogawa T, Uemura H, Yao M, Kubota Y, Kawai M, Okajima K, Kobayashi K, Moriyama M, Kinoshita Y, Mikata K, Kitami K, Masuda M, Saito R, Murai T, Tomoda T, Noguchi S, Sakai N, Hamano A, Nomura S, Sato K.
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M, Matsukawa Y, Kato K, Kondo A, Yamada S, Hattori R, Gotoh M.
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [Abstract] [Full Text] [Related]

  • 3. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O, Miyazaki K, Ishida T, Fujita Y, Hisazumi H.
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [Abstract] [Full Text] [Related]

  • 4. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H, Uchida M, Kojima M.
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [Abstract] [Full Text] [Related]

  • 5. Comparison of three disease-specific quality-of-life questionnaires (Bristol Female Lower Urinary Tract Symptoms, Incontinence Quality of Life and King's Health Questionnaire) in women with stress urinary incontinence.
    Oh SJ, Ku JH.
    Scand J Urol Nephrol; 2007 Mar; 41(1):66-71. PubMed ID: 17366105
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of clenbuterol and propiverine in menopausal women with urinary incontinence: improvement in quality of life.
    Ushiroyama T, Ikeda A, Ueki M.
    J Med; 2000 Mar; 31(5-6):311-9. PubMed ID: 11508324
    [Abstract] [Full Text] [Related]

  • 7. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    Chapple CR, Van Kerrebroeck PE, Jünemann KP, Wang JT, Brodsky M.
    BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
    [Abstract] [Full Text] [Related]

  • 8. Psychometric validation of the Japanese version of the International Consultation on Incontinence Questionnaire-Short Form.
    Gotoh M, Homma Y, Funahashi Y, Matsukawa Y, Kato M.
    Int J Urol; 2009 Mar; 16(3):303-6. PubMed ID: 19207608
    [Abstract] [Full Text] [Related]

  • 9. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W, Stolzenburg JU, Griebenow R, Halaska M, Brünjes R, Frank M, Wieners F.
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [Abstract] [Full Text] [Related]

  • 10. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y, Kojima Y, Shibata Y, Imura M, Kohri K, Sasaki S.
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [Abstract] [Full Text] [Related]

  • 11. Clinical effect of propiverine in patients with urge or stress incontinence. Kobe University Incontinence Study Group.
    Okada H, Sengoku J, Gohji K, Arakawa S, Kamidono S.
    Hinyokika Kiyo; 1998 Jan; 44(1):65-9. PubMed ID: 9503214
    [Abstract] [Full Text] [Related]

  • 12. [Assessments of quality of life in women with urinary incontinence using: King's Health Questionnaire and International Consultation on Incontinence Questionnaire-Short Form].
    Ito H, Hagiwara M, Furuuchi T, Kanai K, Kodaira K, Ninomiya A, Nakamura S.
    Hinyokika Kiyo; 2010 May; 56(5):255-9. PubMed ID: 20519922
    [Abstract] [Full Text] [Related]

  • 13. Does condition-specific quality of life correlate with generic health-related quality of life and objective incontinence severity in women with stress urinary incontinence?
    Oh SJ, Ku JH.
    Neurourol Urodyn; 2006 May; 25(4):324-9; discussion 330. PubMed ID: 16534817
    [Abstract] [Full Text] [Related]

  • 14. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K, Masuda M, Noguchi S, Kubota Y, Hosaka M, Senga Y, Sano K, Miyai K, Kanno H, Kitami K, Fujinami K, Miura T, Kondo I, Kawasaki C, Moriyama M, Hara Y, Ida T, Fukuoka H, Nakagawa J, Kitajima N, Fukuda M, Satomi Y, Takahashi T, Yamaguchi T, Shiozaki H.
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [Abstract] [Full Text] [Related]

  • 15. Impact of fesoterodine on quality of life: pooled data from two randomized trials.
    Kelleher CJ, Tubaro A, Wang JT, Kopp Z.
    BJU Int; 2008 Jul; 102(1):56-61. PubMed ID: 18564231
    [Abstract] [Full Text] [Related]

  • 16. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
    Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM.
    BJU Int; 2005 Jan; 95(1):81-5. PubMed ID: 15638900
    [Abstract] [Full Text] [Related]

  • 17. Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire.
    Engström G, Henningsohn L, Walker-Engström ML, Leppert J.
    Scand J Urol Nephrol; 2006 Jan; 40(6):485-94. PubMed ID: 17130101
    [Abstract] [Full Text] [Related]

  • 18. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D, Wehnert J, Dorschner W, Schubert G, Herfurth G, Alken RG.
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [Abstract] [Full Text] [Related]

  • 19. [The effect of a vaginal device on urinary leakage and quality of life of women with stress urinary incontinence].
    Sander P, Thyssen HH, Lose G, Andersen JT.
    Ugeskr Laeger; 2000 May 22; 162(21):3038-41. PubMed ID: 10850193
    [Abstract] [Full Text] [Related]

  • 20. Patient reported outcomes tools in an observational study of female stress urinary incontinence.
    van de Vaart H, Falconer C, Quail D, Timlin L, Manning M, Tincello D, Tunn R.
    Neurourol Urodyn; 2010 Mar 22; 29(3):348-53. PubMed ID: 19283868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.